dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs121434592
Current Build 157
Released September 3, 2024
- Organism
- Homo sapiens
- Position
-
chr14:104780214 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- C>A / C>G / C>T
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
-
T=0.000008 (1/118672, ExAC)T=0.075 (59/788, PRJEB37584)T=0.000 (0/476, ALFA)
- Clinical Significance
- Reported in ClinVar
- Gene : Consequence
- AKT1 : Stop Gained
- Publications
- 26 citations
- Genomic View
- See rs on genome
ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.
Population | Group | Sample Size | Ref Allele | Alt Allele | Ref HMOZ | Alt HMOZ | HTRZ | HWEP |
---|---|---|---|---|---|---|---|---|
Total | Global | 476 | C=1.000 | T=0.000 | 1.0 | 0.0 | 0.0 | N/A |
European | Sub | 0 | C=0 | T=0 | 0 | 0 | 0 | N/A |
African | Sub | 424 | C=1.000 | T=0.000 | 1.0 | 0.0 | 0.0 | N/A |
African Others | Sub | 0 | C=0 | T=0 | 0 | 0 | 0 | N/A |
African American | Sub | 424 | C=1.000 | T=0.000 | 1.0 | 0.0 | 0.0 | N/A |
Asian | Sub | 0 | C=0 | T=0 | 0 | 0 | 0 | N/A |
East Asian | Sub | 0 | C=0 | T=0 | 0 | 0 | 0 | N/A |
Other Asian | Sub | 0 | C=0 | T=0 | 0 | 0 | 0 | N/A |
Latin American 1 | Sub | 0 | C=0 | T=0 | 0 | 0 | 0 | N/A |
Latin American 2 | Sub | 0 | C=0 | T=0 | 0 | 0 | 0 | N/A |
South Asian | Sub | 0 | C=0 | T=0 | 0 | 0 | 0 | N/A |
Other | Sub | 52 | C=1.00 | T=0.00 | 1.0 | 0.0 | 0.0 | N/A |
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
DownloadStudy | Population | Group | Sample Size | Ref Allele | Alt Allele |
---|---|---|---|---|---|
ExAC | Global | Study-wide | 118672 | C=0.999992 | T=0.000008 |
ExAC | Europe | Sub | 71544 | C=0.99999 | T=0.00001 |
ExAC | Asian | Sub | 24836 | C=1.00000 | T=0.00000 |
ExAC | American | Sub | 11390 | C=1.00000 | T=0.00000 |
ExAC | African | Sub | 10022 | C=1.00000 | T=0.00000 |
ExAC | Other | Sub | 880 | C=1.000 | T=0.000 |
CNV burdens in cranial meningiomas | Global | Study-wide | 788 | C=0.925 | T=0.075 |
CNV burdens in cranial meningiomas | CRM | Sub | 788 | C=0.925 | T=0.075 |
Allele Frequency Aggregator | Total | Global | 476 | C=1.000 | T=0.000 |
Allele Frequency Aggregator | African | Sub | 424 | C=1.000 | T=0.000 |
Allele Frequency Aggregator | Other | Sub | 52 | C=1.00 | T=0.00 |
Allele Frequency Aggregator | European | Sub | 0 | C=0 | T=0 |
Allele Frequency Aggregator | Latin American 1 | Sub | 0 | C=0 | T=0 |
Allele Frequency Aggregator | Latin American 2 | Sub | 0 | C=0 | T=0 |
Allele Frequency Aggregator | South Asian | Sub | 0 | C=0 | T=0 |
Allele Frequency Aggregator | Asian | Sub | 0 | C=0 | T=0 |
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
Sequence name | Change |
---|---|
GRCh38.p14 chr 14 | NC_000014.9:g.104780214C>A |
GRCh38.p14 chr 14 | NC_000014.9:g.104780214C>G |
GRCh38.p14 chr 14 | NC_000014.9:g.104780214C>T |
GRCh37.p13 chr 14 | NC_000014.8:g.105246551C>A |
GRCh37.p13 chr 14 | NC_000014.8:g.105246551C>G |
GRCh37.p13 chr 14 | NC_000014.8:g.105246551C>T |
AKT1 RefSeqGene (LRG_721) | NG_012188.1:g.20531G>T |
AKT1 RefSeqGene (LRG_721) | NG_012188.1:g.20531G>C |
AKT1 RefSeqGene (LRG_721) | NG_012188.1:g.20531G>A |
Molecule type | Change | Amino acid[Codon] | SO Term |
---|---|---|---|
AKT1 transcript variant 1 | NM_005163.2:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_005154.2:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant 1 | NM_005163.2:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_005154.2:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant 1 | NM_005163.2:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_005154.2:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant 3 | NM_001014431.2:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001014431.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant 3 | NM_001014431.2:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001014431.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant 3 | NM_001014431.2:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001014431.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant 2 | NM_001014432.2:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001014432.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant 2 | NM_001014432.2:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001014432.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant 2 | NM_001014432.2:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001014432.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant 4 | NM_001382430.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369359.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant 4 | NM_001382430.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369359.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant 4 | NM_001382430.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369359.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant 7 | NM_001382433.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369362.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant 7 | NM_001382433.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369362.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant 7 | NM_001382433.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369362.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant 6 | NM_001382432.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369361.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant 6 | NM_001382432.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369361.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant 6 | NM_001382432.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369361.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant 5 | NM_001382431.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369360.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant 5 | NM_001382431.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369360.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant 5 | NM_001382431.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase | NP_001369360.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant X1 | XM_047431069.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287025.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant X1 | XM_047431069.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287025.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant X1 | XM_047431069.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287025.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant X2 | XM_047431070.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287026.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant X2 | XM_047431070.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287026.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant X2 | XM_047431070.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287026.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant X3 | XM_047431071.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287027.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant X3 | XM_047431071.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287027.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant X3 | XM_047431071.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287027.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant X4 | XM_047431072.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287028.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant X4 | XM_047431072.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287028.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant X4 | XM_047431072.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287028.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant X5 | XM_047431073.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287029.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant X5 | XM_047431073.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287029.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant X5 | XM_047431073.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287029.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant X6 | XM_047431074.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287030.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant X6 | XM_047431074.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287030.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant X6 | XM_047431074.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287030.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
AKT1 transcript variant X7 | XM_047431075.1:c.49G>T | E [GAG] > * [TAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287031.1:p.Glu17Ter | E (Glu) > * (Ter) | Stop Gained |
AKT1 transcript variant X7 | XM_047431075.1:c.49G>C | E [GAG] > Q [CAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287031.1:p.Glu17Gln | E (Glu) > Q (Gln) | Missense Variant |
AKT1 transcript variant X7 | XM_047431075.1:c.49G>A | E [GAG] > K [AAG] | Coding Sequence Variant |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287031.1:p.Glu17Lys | E (Glu) > K (Lys) | Missense Variant |
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
ClinVar Accession | Disease Names | Clinical Significance |
---|---|---|
RCV000015017.4 | Breast adenocarcinoma | Pathogenic |
RCV000015018.4 | Carcinoma of colon | Pathogenic |
RCV000015019.4 | Ovarian neoplasm | Pathogenic |
RCV000031926.9 | Proteus syndrome | Pathogenic |
RCV000419412.1 | Prostate adenocarcinoma | Likely-Pathogenic |
RCV000421009.1 | Thyroid tumor | Likely-Pathogenic |
RCV000421696.1 | Bone osteosarcoma | Likely-Pathogenic |
RCV000421850.1 | Small cell lung carcinoma | Likely-Pathogenic |
RCV000426386.1 | Malignant melanoma of skin | Likely-Pathogenic |
RCV000427484.1 | Gastric adenocarcinoma | Likely-Pathogenic |
RCV000429060.1 | Neoplasm of the large intestine | Pathogenic |
RCV000430173.1 | Breast neoplasm | Pathogenic |
RCV000431237.1 | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | Likely-Pathogenic |
RCV000431723.1 | Lung adenocarcinoma | Likely-Pathogenic |
RCV000434120.1 | Tumor of meninges | Likely-Pathogenic |
RCV000436698.1 | Non-small cell lung carcinoma | Pathogenic |
RCV000438154.1 | Neoplasm of uterine cervix | Likely-Pathogenic |
RCV000439982.1 | Squamous cell carcinoma of the head and neck | Likely-Pathogenic |
RCV000440828.1 | Squamous cell lung carcinoma | Likely-Pathogenic |
RCV000443761.1 | Transitional cell carcinoma of the bladder | Likely-Pathogenic |
RCV000444311.1 | Hepatocellular carcinoma | Likely-Pathogenic |
RCV000445271.1 | Prostate neoplasm | Likely-Pathogenic |
RCV000795313.6 | Cowden syndrome 6 | Pathogenic |
RCV001813745.2 | not provided | Pathogenic |
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
Placement | C= | A | G | T |
---|---|---|---|---|
GRCh38.p14 chr 14 | NC_000014.9:g.104780214= | NC_000014.9:g.104780214C>A | NC_000014.9:g.104780214C>G | NC_000014.9:g.104780214C>T |
GRCh37.p13 chr 14 | NC_000014.8:g.105246551= | NC_000014.8:g.105246551C>A | NC_000014.8:g.105246551C>G | NC_000014.8:g.105246551C>T |
AKT1 RefSeqGene (LRG_721) | NG_012188.1:g.20531= | NG_012188.1:g.20531G>T | NG_012188.1:g.20531G>C | NG_012188.1:g.20531G>A |
AKT1 transcript variant 1 | NM_005163.2:c.49= | NM_005163.2:c.49G>T | NM_005163.2:c.49G>C | NM_005163.2:c.49G>A |
AKT1 transcript variant 2 | NM_001014432.2:c.49= | NM_001014432.2:c.49G>T | NM_001014432.2:c.49G>C | NM_001014432.2:c.49G>A |
AKT1 transcript variant 2 | NM_001014432.1:c.49= | NM_001014432.1:c.49G>T | NM_001014432.1:c.49G>C | NM_001014432.1:c.49G>A |
AKT1 transcript variant 3 | NM_001014431.2:c.49= | NM_001014431.2:c.49G>T | NM_001014431.2:c.49G>C | NM_001014431.2:c.49G>A |
AKT1 transcript variant 3 | NM_001014431.1:c.49= | NM_001014431.1:c.49G>T | NM_001014431.1:c.49G>C | NM_001014431.1:c.49G>A |
AKT1 transcript variant 7 | NM_001382433.1:c.49= | NM_001382433.1:c.49G>T | NM_001382433.1:c.49G>C | NM_001382433.1:c.49G>A |
AKT1 transcript variant 6 | NM_001382432.1:c.49= | NM_001382432.1:c.49G>T | NM_001382432.1:c.49G>C | NM_001382432.1:c.49G>A |
AKT1 transcript variant 4 | NM_001382430.1:c.49= | NM_001382430.1:c.49G>T | NM_001382430.1:c.49G>C | NM_001382430.1:c.49G>A |
AKT1 transcript variant 5 | NM_001382431.1:c.49= | NM_001382431.1:c.49G>T | NM_001382431.1:c.49G>C | NM_001382431.1:c.49G>A |
AKT1 transcript variant X6 | XM_047431074.1:c.49= | XM_047431074.1:c.49G>T | XM_047431074.1:c.49G>C | XM_047431074.1:c.49G>A |
AKT1 transcript variant X1 | XM_047431069.1:c.49= | XM_047431069.1:c.49G>T | XM_047431069.1:c.49G>C | XM_047431069.1:c.49G>A |
AKT1 transcript variant X5 | XM_047431073.1:c.49= | XM_047431073.1:c.49G>T | XM_047431073.1:c.49G>C | XM_047431073.1:c.49G>A |
AKT1 transcript variant X2 | XM_047431070.1:c.49= | XM_047431070.1:c.49G>T | XM_047431070.1:c.49G>C | XM_047431070.1:c.49G>A |
AKT1 transcript variant X3 | XM_047431071.1:c.49= | XM_047431071.1:c.49G>T | XM_047431071.1:c.49G>C | XM_047431071.1:c.49G>A |
AKT1 transcript variant X4 | XM_047431072.1:c.49= | XM_047431072.1:c.49G>T | XM_047431072.1:c.49G>C | XM_047431072.1:c.49G>A |
AKT1 transcript variant X7 | XM_047431075.1:c.49= | XM_047431075.1:c.49G>T | XM_047431075.1:c.49G>C | XM_047431075.1:c.49G>A |
RAC-alpha serine/threonine-protein kinase | NP_005154.2:p.Glu17= | NP_005154.2:p.Glu17Ter | NP_005154.2:p.Glu17Gln | NP_005154.2:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase | NP_001014432.1:p.Glu17= | NP_001014432.1:p.Glu17Ter | NP_001014432.1:p.Glu17Gln | NP_001014432.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase | NP_001014431.1:p.Glu17= | NP_001014431.1:p.Glu17Ter | NP_001014431.1:p.Glu17Gln | NP_001014431.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase | NP_001369362.1:p.Glu17= | NP_001369362.1:p.Glu17Ter | NP_001369362.1:p.Glu17Gln | NP_001369362.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase | NP_001369361.1:p.Glu17= | NP_001369361.1:p.Glu17Ter | NP_001369361.1:p.Glu17Gln | NP_001369361.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase | NP_001369359.1:p.Glu17= | NP_001369359.1:p.Glu17Ter | NP_001369359.1:p.Glu17Gln | NP_001369359.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase | NP_001369360.1:p.Glu17= | NP_001369360.1:p.Glu17Ter | NP_001369360.1:p.Glu17Gln | NP_001369360.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287030.1:p.Glu17= | XP_047287030.1:p.Glu17Ter | XP_047287030.1:p.Glu17Gln | XP_047287030.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287025.1:p.Glu17= | XP_047287025.1:p.Glu17Ter | XP_047287025.1:p.Glu17Gln | XP_047287025.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287029.1:p.Glu17= | XP_047287029.1:p.Glu17Ter | XP_047287029.1:p.Glu17Gln | XP_047287029.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287026.1:p.Glu17= | XP_047287026.1:p.Glu17Ter | XP_047287026.1:p.Glu17Gln | XP_047287026.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287027.1:p.Glu17= | XP_047287027.1:p.Glu17Ter | XP_047287027.1:p.Glu17Gln | XP_047287027.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287028.1:p.Glu17= | XP_047287028.1:p.Glu17Ter | XP_047287028.1:p.Glu17Gln | XP_047287028.1:p.Glu17Lys |
RAC-alpha serine/threonine-protein kinase isoform X1 | XP_047287031.1:p.Glu17= | XP_047287031.1:p.Glu17Ter | XP_047287031.1:p.Glu17Gln | XP_047287031.1:p.Glu17Lys |
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
No | Submitter | Submission ID | Date (Build) |
---|---|---|---|
1 | OMIM-CURATED-RECORDS | ss256302345 | Aug 26, 2010 (132) |
2 | GENEREVIEWS | ss539219251 | Oct 10, 2012 (137) |
3 | EVA_EXAC | ss1691656433 | Apr 01, 2015 (144) |
4 | GNOMAD | ss2740988744 | Nov 08, 2017 (151) |
5 | ILLUMINA | ss3625668160 | Oct 12, 2018 (152) |
6 | ILLUMINA | ss3725480206 | Jul 13, 2019 (153) |
7 | EVA | ss3984697828 | Apr 26, 2021 (155) |
8 | YEGNASUBRAMANIAN_LAB | ss6345868726 | Nov 03, 2024 (157) |
9 | EVA | ss6349885208 | Nov 03, 2024 (157) |
10 | EVA | ss6403987361 | Nov 03, 2024 (157) |
11 | CPQ_GEN_INCA | ss8236857257 | Nov 03, 2024 (157) |
12 | CSS-BFX | ss8442109898 | Nov 03, 2024 (157) |
13 | EVA | ss8936208207 | Nov 03, 2024 (157) |
14 | EVA | ss8981400719 | Nov 03, 2024 (157) |
15 | EVA | ss8981485921 | Nov 03, 2024 (157) |
16 | ExAC | NC_000014.8 - 105246551 | Oct 12, 2018 (152) |
17 | CNV burdens in cranial meningiomas | NC_000014.8 - 105246551 | Apr 26, 2021 (155) |
18 | ALFA | NC_000014.9 - 104780214 | Nov 03, 2024 (157) |
19 | ClinVar | RCV000015017.4 | Oct 12, 2018 (152) |
20 | ClinVar | RCV000015018.4 | Oct 12, 2018 (152) |
21 | ClinVar | RCV000015019.4 | Oct 12, 2018 (152) |
22 | ClinVar | RCV000031926.9 | Nov 03, 2024 (157) |
23 | ClinVar | RCV000419412.1 | Oct 12, 2018 (152) |
24 | ClinVar | RCV000421009.1 | Oct 12, 2018 (152) |
25 | ClinVar | RCV000421696.1 | Oct 12, 2018 (152) |
26 | ClinVar | RCV000421850.1 | Oct 12, 2018 (152) |
27 | ClinVar | RCV000426386.1 | Oct 12, 2018 (152) |
28 | ClinVar | RCV000427484.1 | Oct 12, 2018 (152) |
29 | ClinVar | RCV000429060.1 | Oct 12, 2018 (152) |
30 | ClinVar | RCV000430173.1 | Oct 12, 2018 (152) |
31 | ClinVar | RCV000431237.1 | Oct 12, 2018 (152) |
32 | ClinVar | RCV000431723.1 | Oct 12, 2018 (152) |
33 | ClinVar | RCV000434120.1 | Oct 12, 2018 (152) |
34 | ClinVar | RCV000436698.1 | Oct 12, 2018 (152) |
35 | ClinVar | RCV000438154.1 | Oct 12, 2018 (152) |
36 | ClinVar | RCV000439982.1 | Oct 12, 2018 (152) |
37 | ClinVar | RCV000440828.1 | Oct 12, 2018 (152) |
38 | ClinVar | RCV000443761.1 | Oct 12, 2018 (152) |
39 | ClinVar | RCV000444311.1 | Oct 12, 2018 (152) |
40 | ClinVar | RCV000445271.1 | Oct 12, 2018 (152) |
41 | ClinVar | RCV000795313.6 | Nov 03, 2024 (157) |
42 | ClinVar | RCV001813745.2 | Nov 03, 2024 (157) |
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
Submission IDs | Observation SPDI | Canonical SPDI | Source RSIDs |
---|---|---|---|
ss8936208207 | NC_000014.8:105246550:C:A | NC_000014.9:104780213:C:A | (self) |
ss6349885208, ss8936208207 | NC_000014.8:105246550:C:G | NC_000014.9:104780213:C:G | (self) |
2015682, 247346, ss1691656433, ss2740988744, ss3625668160, ss3984697828, ss6345868726, ss6403987361, ss8236857257, ss8442109898, ss8936208207, ss8981400719, ss8981485921 | NC_000014.8:105246550:C:T | NC_000014.9:104780213:C:T | (self) |
RCV000015017.4, RCV000015018.4, RCV000015019.4, RCV000031926.9, RCV000419412.1, RCV000421009.1, RCV000421696.1, RCV000421850.1, RCV000426386.1, RCV000427484.1, RCV000429060.1, RCV000430173.1, RCV000431237.1, RCV000431723.1, RCV000434120.1, RCV000436698.1, RCV000438154.1, RCV000439982.1, RCV000440828.1, RCV000443761.1, RCV000444311.1, RCV000445271.1, RCV000795313.6, RCV001813745.2, 383682332, ss256302345, ss539219251, ss3725480206 | NC_000014.9:104780213:C:T | NC_000014.9:104780213:C:T | (self) |
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
PMID | Title | Author | Year | Journal |
---|---|---|---|---|
17611497 | A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. | Carpten JD et al. | 2007 | Nature |
18504432 | AKT1(E17K) in human solid tumours. | Bleeker FE et al. | 2008 | Oncogene |
18611285 | Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting. | Do H et al. | 2008 | BMC research notes |
19418217 | Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma. | Dunlap J et al. | 2010 | Breast cancer research and treatment |
19487299 | Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. | Ricarte-Filho JC et al. | 2009 | Cancer research |
19853286 | AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma. | Cohen Y et al. | 2010 | Gynecologic oncology |
20233444 | A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes. | Fumagalli D et al. | 2010 | BMC cancer |
20453058 | Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models. | O'Brien C et al. | 2010 | Clinical cancer research |
21464312 | Deactivation of Akt by a small molecule inhibitor targeting pleckstrin homology domain and facilitating Akt ubiquitination. | Jo H et al. | 2011 | Proceedings of the National Academy of Sciences of the United States of America |
21512767 | Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes. | Boyault S et al. | 2012 | Breast cancer research and treatment |
21793738 | A mosaic activating mutation in AKT1 associated with the Proteus syndrome. | Lindhurst MJ et al. | 2011 | The New England journal of medicine |
22538770 | Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers. | Santarpia L et al. | 2012 | Breast cancer research and treatment |
22610119 | Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. | Barbieri CE et al. | 2012 | Nature genetics |
22722201 | The landscape of cancer genes and mutational processes in breast cancer. | Stephens PJ et al. | 2012 | Nature |
22722839 | The mutational landscape of lethal castration-resistant prostate cancer. | Grasso CS et al. | 2012 | Nature |
22876373 | Proteus Syndrome. | Biesecker LG et al. | 1993 | GeneReviews(®) |
22980975 | Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. | Imielinski M et al. | 2012 | Cell |
23237847 | Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine. | Yi KH et al. | 2013 | Oncotarget |
23348505 | Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. | Clark VE et al. | 2013 | Science (New York, N.Y.) |
23700467 | Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing. | Han SW et al. | 2013 | PloS one |
23728071 | A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features. | Trigka EA et al. | 2013 | Oncology reports |
23934607 | Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis. | Neumann J et al. | 2013 | Virchows Archiv |
24190505 | Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas. | Joseph CG et al. | 2014 | Genes, chromosomes & cancer |
24657128 | Molecular profiling of small cell lung cancer in a Japanese cohort. | Wakuda K et al. | 2014 | Lung cancer (Amsterdam, Netherlands) |
25157968 | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | MacConaill LE et al. | 2014 | The Journal of molecular diagnostics |
26619011 | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | Chang MT et al. | 2016 | Nature biotechnology |
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.